Dragana Spasic

Dr. Dragana Spasic

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2020 in Micromachines
Verified
Journal Article
Open access
PDF file
PKPhalguni Tewari Kumar
Phalguni Tewari Kumar
DDDeborah Decrop
Deborah Decrop
SSSaba Safdar
Saba Safdar
IPIoannis Passaris
Ioannis Passaris
TKTadej Kokalj
Tadej Kokalj
Jeroen LammertynJeroen Lammertyn
Jeroen Lammertyn
When screening microbial populations or consortia for interesting cells, their selective retrieval for further study can be of great interest. To this end, traditional fluorescence activated cell sorting (FACS) and optical tweezers (OT) enabled methods have typically been used. However, the former, although allowing cell sorting, fails to track dynamic cell behavior, while the latter has been limited to complex channel-based microfluidic platforms. In this study, digital microfluidics (DMF) was integrated with OT for selective trapping, relocation, and further proliferation of single bacterial cells, while offering continuous imaging of cells to evaluate dynamic cell behavior. To enable this, magnetic beads coated with Salmonella Typhimurium-targeting antibodies were seeded in the microwell array of the DMF platform, and used to capture single cells of a fluorescent S. Typhimurium population. Next, OT were used to select a bead with a bacterium of interest, based on its fluorescent expression, and to relocate this bead to a different microwell on the same or different array. Using an agar patch affixed on top, the relocated bacterium was subsequently allowed to proliferate. Our OT-integrated DMF platform thus successfully enabled selective trapping, retrieval, relocation, and proliferation of bacteria of interest at single-cell level, thereby enabling their downstream analysis.

Verified
Journal Article
Open access
PDF file
YYYagmur Yildizhan
Yagmur Yildizhan
KDKaat Driessens
Kaat Driessens
HTHong Shen Kevin Tsao
Hong Shen Kevin Tsao
RBRobin Boiy
Robin Boiy
DTDebby Thomas
Debby Thomas
DSDragana Spasic
Dragana Spasic
Extracellular vesicles (EVs) have attracted great attention as potential biomarkers for cancer diagnostics. Although several technologies have been developed for EV detection, many of them are still not applicable to clinical settings as they rely on complex EV isolation processes, while lacking sensitivity, specificity or standardization. To solve this problem, we have developed a sensitive breast cancer-specific EV detection bioassay directly in blood plasma using a fiber-optic surface plasmon resonance (FO-SPR) biosensor, previously calibrated with recombinant EVs. First, we established a sandwich bioassay to detect SK-BR-3 EVs by functionalizing the FO-SPR probes with anti-HER2 antibodies. A calibration curve was built using an anti-HER2/Banti-CD9 combination, resulting in an LOD of 2.1 × 107 particles/mL in buffer and 7 × 108 particles/mL in blood plasma. Next, we investigated the potential of the bioassay to detect MCF7 EVs in blood plasma using an anti-EpCAM/Banti-mix combination, obtaining an LOD of 1.1 × 10 8 particles/mL. Finally, the specificity of the bioassay was proven by the absence of signal when testing plasma samples from 10 healthy people unknown to be diagnosed with breast cancer. The remarkable sensitivity and specificity of the developed sandwich bioassay together with the advantages of the standardized FO-SPR biosensor highlight outstanding potential for the future of EV analysis.

1 December 2020 in Trends in Biotechnology
Verified
Journal Article
Closed access
SSSaba Safdar
Saba Safdar
Jeroen LammertynJeroen Lammertyn
Jeroen Lammertyn
DSDragana Spasic
Dragana Spasic

8 November 2022 in Trends in Biotechnology
Verified
Journal Article
Closed access
CTCharlotte Van Tricht
Charlotte Van Tricht
TVThierry Voet
Thierry Voet
Jeroen LammertynJeroen Lammertyn
Jeroen Lammertyn
DSDragana Spasic
Dragana Spasic

25 March 2022 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
HOHenry Ordutowski
Henry Ordutowski
FDFrancesco Dal Dosso
Francesco Dal Dosso
WWWout De Wispelaere
Wout De Wispelaere
CTCharlotte Van Tricht
Charlotte Van Tricht
SVSéverine Vermeire
Séverine Vermeire
Jeroen LammertynJeroen Lammertyn
Jeroen Lammertyn

31 July 2017 in Sensors
Verified
Journal Article
Open access
PDF file
DDDevin Daems
Devin Daems
BPBernd Peeters
Bernd Peeters
FDFilip Delport
Filip Delport
TRTony Remans
Tony Remans
Jeroen LammertynJeroen Lammertyn
Jeroen Lammertyn
DSDragana Spasic
Dragana Spasic
Accurate identification and quantification of allergens is key in healthcare, biotechnology and food quality and safety. Celery (Apium graveolens) is one of the most important elicitors of food allergic reactions in Europe. Currently, the golden standards to identify, quantify and discriminate celery in a biological sample are immunoassays and two-step molecular detection assays in which quantitative PCR (qPCR) is followed by a high-resolution melting analysis (HRM). In order to provide a DNA-based, rapid and simple detection method suitable for one-step quantification, a fiber optic PCR melting assay (FO-PCR-MA) was developed to determine different concentrations of celery DNA (1 pM–0.1 fM). The presented method is based on the hybridization and melting of DNA-coated gold nanoparticles to the FO sensor surface in the presence of the target gene (mannitol dehydrogenase, Mtd). The concept was not only able to reveal the presence of celery DNA, but also allowed for the cycle-to-cycle quantification of the target sequence through melting analysis. Furthermore, the developed bioassay was benchmarked against qPCR followed by HRM, showing excellent agreement (R2 = 0.96). In conclusion, this innovative and sensitive diagnostic test could further improve food quality control and thus have a large impact on allergen induced healthcare problems.